Potentiation of cellular immunity using histone deacetylase (HDAC) inhibitors

Details for Australian Patent Application No. 2007328872 (hide)

Owner Japan Science and Technology Agency Sapporo Medical University

Inventors Asanuma, Hiroko; Torigoe, Toshihiko; Sato, Noriyuki; Fujii, Nobuhiro; Ishino, Masaho

Agent Spruson & Ferguson

Pub. Number AU-A-2007328872

PCT Pub. Number WO2008/069349

Priority 60/873,223 06.12.06 US

Filing date 6 December 2007

Wipo publication date 12 June 2008

International Classifications

A61K 31/19 (2006.01)

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07C 53/128 (2006.01) Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen

Event Publications

18 June 2009 PCT application entered the National Phase

  PCT publication WO2008/069349 Priority application(s): WO2008/069349

12 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007328887-Antibacterial quinoline derivatives

2007328871-Pharmaceutical agent having longlasting effect of treating arthritic disorders